Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volu-Flow: Hemodynamic Effects of Ringer's Acetate in Healthy Volunteers
NCT05705115Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Mar 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ringer's acetate in hypovolemia (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Cardiac stroke volume at 120 minutes. Started Mar 2024; status: completed.
02
Drugs
ringer's acetate
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT05705115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705115.